Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. (SNDX) — Form SCHEDULE 13G: Ownership over 5% (passive)
About this filing
Syndax Pharmaceuticals, Inc. (SNDX) filed Form SCHEDULE 13G (ownership over 5% (passive)) with the SEC on Aug 7, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.
Key facts
- Document
- —
More SNDX filings
- 4
Filed Oct 30, 2026
- 144
Filed Oct 29, 2026
- 10-Q
Filed Aug 4, 2026
- 8-K
Filed Aug 4, 2026
- 8-K
Filed Jul 14, 2026
- 4
Filed Jul 9, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.